Short Squeeze Scan — 2026-06-21

Algolearn.AI June 21, 2026 4 min read 9 views


Squeeze 2026-06-21 · 0 top setups · 9 watchlist · 21 no signal

Automated daily scan of high-short-interest US stocks, scored against a 7-point short-squeeze checklist (the same warning signs that preceded the April 2026 CAR squeeze). Each top setup includes a defined-risk options idea built from live chain data. Not investment advice.

Top setups

No qualifying setups today.

Watchlist

TickerScoreSummary
GRPN4/7Groupon sports the universe's highest SI at 62.52% float and ~11 days-to-cover, providing massive mechanical squeeze fuel if a catalyst fires. The Jul-17 options chain confirms the thesis: call 25d IV trades at 142% vs 41% for puts (skew -71%), with calls priced at 5x put premium — aggressive directional bet on a squeeze. The fatal flaw is a 0.54% borrow rate (easy-to-borrow), which removes carry pain for shorts, and price is in a -27.7% downtrend from peak. Watch for price reversal above $18 with August 12 earnings as the potential ignition event.
FLWS4/71-800-Flowers is a textbook pre-squeeze coil: 45.21% SI, 31.58 days-to-cover (shares available as low as 25K at primes), 2.73% borrow APR, and Jul-17 OTM calls priced at 299% IV signal a market pricing in an explosive covering event. The missing ingredient is price momentum — the stock drifts lower with no near-term catalyst on the horizon until August earnings. This setup requires a catalyst trigger; without one, the short base can be patiently maintained at 2.73% carry.
SPRY4/7ARS Pharmaceuticals combines 13.89 days-to-cover (nearly 3 weeks of mechanical fuel) with a multi-stage EU/global catalyst pipeline for neffy and a steady +34.6% price uptrend confirming short covering. Options show call 25d IV at 203% vs 99% for puts (skew -51.5%), aligning with the squeeze thesis. The setup misses the 40% SI threshold by 2.9 percentage points — if the Nasdaq-reported 41.46% float figure is more current, this crosses into top-setup territory. Monitor EU CHMP final decision date as the next potential ignition.
PCT3/7PureCycle has 45.88% SI, 6.01% borrow rate, and ~7 DTC — the full mechanical squeeze infrastructure — but a catastrophic June 9-11 breakdown (37M shares, -38.7% from peak) overwhelmed the setup with what appears to be a negative fundamental event. With SI intact at 45.88% and borrow elevated, a squeeze could materialize if the selloff was technical rather than fundamental; confirm the Jun 11 catalyst and watch for stabilization above $8.70 before engaging.
WYFI3/7WhiteFiber is in an active squeeze-in-progress: +77.71% in 30 days driven by a fresh $100M AI/HPC loan catalyst (June 18) and speculative call-option surge (ATM IV 237%, skew -44%). The tight 11.19M float with 71% non-float shares creates outsized price sensitivity to any incremental buying. The mechanical squeeze fuel is modest (34.13% SI, 3.1 DTC), so this is primarily a momentum/AI-narrative trade rather than a classic short-cover squeeze; the move may already be significantly advanced.
EOSE3/7Eos Energy's Turbine-X AI data center JDA (2 GWh) and $303.5M DOE loan guarantee triggered aggressive short covering in recent sessions, with Jun-17 volume hitting 47M (+11.6% that day) and the Jun-26 chain showing extreme call skew: call 25d IV 218% vs put 25d IV 70% (skew -68%), with calls at 3.8x put premium. The 335M-share float is the primary constraint — DTC is only ~3.5 days — making this a narrative/catalyst trade rather than a mechanical squeeze; the AI battery storage theme is the engine.
HIMS3/7Hims & Hers is forcing significant mark-to-market pain on its 30% short float: the stock surged +60.2% in one month on the GLP-1/Novo Nordisk pivot narrative, with Jun 18 volume hitting 31.8M shares. Options show call 25d IV at 131% vs 101% for puts (skew -22%), confirming directional call positioning. The large 211M-share float prevents a mechanical squeeze — DTC is only 2-3 days — but the fundamental narrative is strong enough to sustain short-covering pressure into Q2 earnings.
FLNC3/7Fluence Energy carries 33.89% SI against a loaded AI-infrastructure catalyst stack — 2 hyperscaler master supply agreements, $5.6B backlog, and a Nvidia/Siemens/Fluence architecture collaboration — that triggered a +43% single-day short-covering explosion on June 1 (45.5M volume). Price has consolidated +38.5% above the May low, with Jul-17 options showing call 25d IV at 151% vs 119% puts (skew -21.5%). DTC is only ~2.2 days, so this is a catalyst-driven squeeze rather than mechanical; the Q3 hyperscaler order conversion is the next ignition point.
BEAM3/7Beam Therapeutics has ~13.3 days-to-cover on 30.3% SI with two approaching clinical catalysts (risto-cel SCD launch, BEAM-103 Phase 1 completion), and price is up +29.7% from May lows on above-average volume. The critical warning: Jul-17 options show a pronounced put skew (+99%), with puts at 2x call IV — the smart money is buying downside protection, not calls. Score 3 but the bearish options divergence from bullish price action warrants caution.

No signal

AEHL, AI, HTZ, SOUN, BATL, WOK, LFVN, LCID, RXRX, EVGO, SERV, TTEC, WGS, UONE, BETR, SATS, PLCE, SPHR, INDI, NFE, IOVA


Generated 2026-06-21 15:11 UTC by the AlgoLearn squeeze scanner. Defined-risk options ideas for informational purposes only — not investment advice.

https://pagerankcafe.com/pressRelease/blog/squeeze-scan-2026-06-21

Share this article

𝕏 Post Facebook LinkedIn Email

Related Articles